Results
|
|
1.
|
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. MedStar authors:
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):235-51, 2016 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Amiri-Kordestani L, Chavez KJ, Conway CM, Dine JL, Greer YE, Hewitt SM, Lipkowitz S, Merchant AS, O'Sullivan CC, Sinclair S, Steinberg SM, Stone B, Swain SM, Voeller D
|
|
|
2.
|
The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells. MedStar authors:
- Boyle, Lisa
- Burman, Kenneth D
- Klubo-Gwiezdzinska, Joanna
- Kushchayeva, Yevgeniya
Citation: - Journal of Clinical Endocrinology & Metabolism. 99(5):E734-45, 2014 May.
Institution: - MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Surgery
Medline publication type:
All authors: - Boyle L, Burman K, Costello J, Jensen K, Klubo-Gwiezdzinska J, Kushchayeva Y, Patel A, Recupero A, Vasko V
|
|
|
3.
|
Glucose-deprivation increases thyroid cancer cells sensitivity to metformin. MedStar authors:
- Bikas, Athanasios
- Burman, Kenneth D
- Klubo-Gwiezdzinska, Joanna
- Wartofsky, Leonard
Year: 2015
Citation: - Endocrine-Related Cancer. 22(6):919-32, 2015 Dec.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Bikas A, Boyle L, Burman KD, Costello J Jr, Hoperia V, Jensen K, Klubo-Gwiezdzinska J, Larin O, McDaniel D, Patel A, Vasko V, Wartofsky L
|
